Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  42.00 3.39% 1,282.00 1,272.00 1,284.00 1,284.00 1,230.00 1,230.00 160,884 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.3 0.7 1.0 1,282.0 506

Biotech Growth Share Discussion Threads

Showing 76 to 95 of 325 messages
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
DateSubjectAuthorDiscuss
21/3/2014
20:38
Market? Think I will buy more; been in since a £1, for my son.
philo124
21/3/2014
19:32
Tough to understand why we're now standing at a near 10% discount to NAV! Anybody got any ideas?
rbdc1
21/3/2014
09:07
hxxp://www.trustnet.com/News/496162/merricks-why-im-buying-the-biotech-growth-trust-for-my-isa/
affemoose
20/3/2014
16:49
Back in at the discount - read somewhere Fund manager is going to use buy backs to protect 6% discount level
bashby
14/2/2014
08:16
IBT- always has been .
philo124
13/2/2014
23:49
IBT buying opportunity. Check on Trustnet, - it's at an unusual discount
yiyack3
10/2/2014
14:17
not now ! nav 520.36 as at 7/2/14. m
maurillac
06/2/2014
13:35
This trust is so entertaining - down 7.8% in a single day, then going up, not good for my heart though!
bigwilly1986
27/1/2014
19:15
Seems to happen every 6 months.
philo124
10/1/2014
13:52
now £5!
affemoose
19/12/2013
20:45
Coincidence, just moved into new house and finally sorted my paperwork out after 3 months in limbo. Came across BIOG paperwork to file and saw my last note-"£4!" bought for my son at £1. So pleased it's up another 10%. As with IBT and PCT these are great to sit alongside yielders that have got no eps growth, Come to think about it, Would have been better forgetting the high yielders.
philo124
19/12/2013
19:15
harry - agree 50% is excellent performance but at the end of the day it's still under performing and lagging behind its peer group/benchmark. IBB the US passive biotech etf is up over 60% , and it only has an expense ratio of 0.48% vs BIOG's TER of 1.31%, 1.31% of a £50,000 investment is £655. You're paying £655 for underperformance and their Christmas bonuses and salaries. ..I'll take 60% any day.
rford78
19/12/2013
17:13
I'm quite happy to stay - if all my picks increased 50% in a year I'd be a rich man!
harry the haddock
19/12/2013
17:07
I also sold out today - same reasoning :)
bashby
19/12/2013
16:49
Sold some of this underperforming miscreant BIOG,after finally seeing some strength today. I'm better off shorting ATM puts instead in IBB (Nasdaq biotech etf) , a passive etf fund which has been beating BIOG (actively maaged) by nearly 10% ytd. The BIOG fund manager has been underperforming for a while and they are doing hardly anything about it, but being unjustifiably paid to collect their undeserved annual fees/TER and fat bonuses.
rford78
18/11/2013
14:09
Discount is greater than 7% as of today morning and has been persisting for couple days now , why won't the fund managers initiate the buyback - it's in the trust's mandate: "...In early 2005, the Company introduced a discount control mechanism, with a commitment to protect a discount of 6% through the buyback of shares, which are then cancelled. This active policy has successfully kept the discount to within acceptable limits...."
rford78
02/8/2013
19:59
MadmixIn fairness the discount been at 14% before.Think it may be approaching a buying opportunity given today's NAV in the 440's
rbdc1
01/8/2013
21:47
rbdc1, Over the past year, this has traded in a range between a 5% discount and 4% premium. So this could be seen as a buying opportunity. www.trustnet.com/Webservices/Charting.asmx/GetDiscountPremiumChart?width=650&height=250&unitCode=AKR0&span=12
madmix
01/8/2013
18:10
Odd that BIOG is now 4% below its NAV when it used to trade at a slight premium...
rbdc1
26/7/2013
21:25
For an actively managed fund, BIOG seems to be lagging the major (passive) biotech etfs (ibb/fbt etc) over the past few months which is dismal given fund manager's hefty fees and annual management charges.
rford78
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200808 13:00:25